Public health officials need to address conspiracy theories surrounding the spread and treatment of HIV/AIDS in African-American communities, comments an editorial in this weeks issue of The Lancet.
A recent U.S. study found that one in seven African-Americans surveyed said they believed that AIDS was created by the government to control the black population, one in three said they believed HIV was produced in a government laboratory, and more than half said that there was a cure for HIV/AIDS that was being withheld from the poor.
While the conspiracy theories are understandable, considering the history of discrimination that African-Americans have faced, there is a real risk that they will frustrate efforts to halt the epidemic in this community, writes the editorial. More than half of new HIV cases reported in the U.S. are in African-Americans.
The Lancet believes that public-health officials working against the spread of HIV/ AIDS need to acknowledge, address and discuss the roots of the conspiracy theories and mistrust prevalent in the African-American community.
Michael McCarthy, North American editor of The Lancet, states: It is unlikely that men and women who believe the government has created HIV will listen to the governments health warnings, come in for testing, or take recommended treatments. To reach those at greatest risk, public-health officials need to recruit and train more black peer educators and need to craft sex education messages that are culturally suited to black Americans. government and health officials must also address the very real discrimination that continues to exist within the U.S. healthcare system. It is also of paramount importance that black community leaders and black media outlets make challenging these conspiracy theories a priority.
Source: The Lancet
Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.
Reducing Hidden Risks: Why Sharps Injuries Still Go Unreported
July 18th 2025Despite being a well-known occupational hazard, sharps injuries continue to occur in health care facilities and are often underreported, underestimated, and inadequately addressed. A recent interview with sharps safety advocate Amanda Heitman, BSN, RN, CNOR, a perioperative educational consultant, reveals why change is overdue and what new tools and guidance can help.
New Study Explores Oral Vancomycin to Prevent C difficile Recurrence, But Questions Remain
July 17th 2025A new clinical trial explores the use of low-dose oral vancomycin to prevent Clostridioides difficile recurrence in high-risk patients taking antibiotics. While the data suggest a possible benefit, the findings stop short of statistical significance and raise red flags about vancomycin-resistant Enterococcus (VRE), underscoring the delicate balance between prevention and antimicrobial stewardship.
The Next Frontier in Infection Control: AI-Driven Operating Rooms
Published: July 15th 2025 | Updated: July 15th 2025Discover how AI-powered sensors, smart surveillance, and advanced analytics are revolutionizing infection prevention in the OR. Herman DeBoard, PhD, discusses how these technologies safeguard sterile fields, reduce SSIs, and help hospitals balance operational efficiency with patient safety.
CDC Urges Vigilance: New Recommendations for Monitoring and Testing H5N1 Exposures
July 11th 2025With avian influenza A(H5N1) infections surfacing in both animals and humans, the CDC has issued updated guidance calling for aggressive monitoring and targeted testing to contain the virus and protect public health.
A Helping Hand: Innovative Approaches to Expanding Hand Hygiene Programs in Acute Care Settings
July 9th 2025Who knew candy, UV lights, and a college kid in scrubs could double hand hygiene adherence? A Pennsylvania hospital’s creative shake-up of its infection prevention program shows that sometimes it takes more than soap to get hands clean—and keep them that way.